{"id":2654,"date":"2008-06-13T11:50:36","date_gmt":"2008-06-13T18:50:36","guid":{"rendered":"http:\/\/www.carlsbadistan.com\/?p=2654"},"modified":"2008-06-13T11:50:49","modified_gmt":"2008-06-13T18:50:49","slug":"invitogens-64-billion-shopping-cart","status":"publish","type":"post","link":"http:\/\/www.carlsbadistan.com\/?p=2654","title":{"rendered":"Invitogen&#8217;s $6.4 Billion Shopping Cart"},"content":{"rendered":"<p>Our favorite Carlsbad-based life sciences company <strong><a href=\"http:\/\/www.invitrogen.com\/\" target=\"_blank\">Invitrogen<\/a><\/strong> just spent $6.4 billion to purchase &#8220;scientific instruments-maker <strong><a href=\"http:\/\/www.applera.com\/\" target=\"_blank\">Applera&#8217;s<\/a><\/strong><strong> <\/strong><strong><a href=\"http:\/\/www3.appliedbiosystems.com\/AB_Home\/index.htm\" target=\"_blank\">Applied Biosystems Group<\/a><\/strong>.&#8221;<\/p>\n<blockquote><p>Invitrogen will pay $38 per share for Applied Biosystems, representing a 17 percent premium to the stock&#8217;s closing price Wednesday. . . . The deal, which needs the approval of both companies&#8217; shareholders, is expected to close this fall.<\/p><\/blockquote>\n<p>About 45 percent of the deal will reportedly be in cash, the rest of stock. Invitrogen&#8217;s shares dropped nearly $6 a share on the news and is now trading at $38.97. Up .24 on the day. <\/p>\n<p>And we thought Invitrogen couldn&#8217;t get any scarier.<\/p>\n<p><strong>[Link: <\/strong><strong><a href=\"http:\/\/www.chicagotribune.com\/business\/chi-fri-brf1-applera-merger-jun13,0,2777014.story\" target=\"_blank\">Chicago Tribune<\/a><\/strong><strong>]<\/strong> <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Our favorite Carlsbad-based life sciences company Invitrogen just spent $6.4 billion to purchase &#8220;scientific instruments-maker Applera&#8217;s Applied Biosystems Group.&#8221; Invitrogen will pay $38 per share for Applied Biosystems, representing a 17 percent premium to the stock&#8217;s closing price Wednesday. . . . The deal, which needs the approval of both companies&#8217; shareholders, is expected to [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[8,34,26],"tags":[],"_links":{"self":[{"href":"http:\/\/www.carlsbadistan.com\/index.php?rest_route=\/wp\/v2\/posts\/2654"}],"collection":[{"href":"http:\/\/www.carlsbadistan.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.carlsbadistan.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.carlsbadistan.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/www.carlsbadistan.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2654"}],"version-history":[{"count":0,"href":"http:\/\/www.carlsbadistan.com\/index.php?rest_route=\/wp\/v2\/posts\/2654\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.carlsbadistan.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.carlsbadistan.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2654"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.carlsbadistan.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}